Uflex: Shielding Pharmaceutical Brands Through End-To-End Packaging And Anti-Counterfeiting Innovations

Amit Shah, Joint President, Flexible Packaging business

Amit Shah

Joint President, Flexible Packaging business

Claimed to be the third largest in the world by volume, the Indian pharmaceutical industry has recorded remark­able growth over the years. But this sector, which hinges on authenticity and trust, has also witnessed a significant rise in the number and sophistication of counterfeiting, particularly in the wake of the pandemic, due to the high demand for drugs and medical supplies. The key for pharmaceutical companies to combat this challenge lies in recognizing the problem and part­nering with an efficient flexible packaging solutions provider who can understand evolving market needs and leverage com­prehensive packaging solutions under one roof, in turn equip­ping them to retain their brand value, credibility, and market position, without the hassle of working with multiple players. Serving as the very definition of such an enabler is Uflex, the largest multi-award-winning multinational flexible packaging solutions company in India.

Established in 1985 in Noida by Ashok Chaturvedi, an illustrious first-generation entrepreneur and a thought leader, Uflex initiated its journey in the FMCG domain by introducing first-of-its-kind unit pouches for mouth fresheners, shampoos, candies, and tomato ketchup in the country, setting the stage for a potential legacy of pioneering first-of-its-kind advancements in the Indian as well as global packaging manufacturing and exporting realms. Slowly expanding its geographical presence and business operations, the company has emerged as a dominant force through its array of comprehensive solutions, innovations, and patented technologies. Today, the firm has expanded its global presence with state-of-the-art manufacturing facilities in India, the UAE, Mexico, Egypt, the USA, Poland, Russia, Nigeria, and Hungary, with Flexible Packaging and Holography plants in Noida and Jammu, apart from its four government-certified R&D labs. Owing to its remarkable contributions, the $2 billion group, Uflex, has garnered various prestigious awards and the trust of clients in over 150 countries spread across North America, Europe, Africa, the Middle East, and Southeast Asia.

Engine Room for Breakthroughs

Highly renowned for its end-to-end flexible packaging and holography solutions, Uflex has also carved a niche in the pharmaceutical industry, working closely with brands to protect their identity while incorporating both overt and covert tamper-evident anti-counterfeiting features into their product designs. This allows the consumers to clearly differentiate between genuine and spurious drugs or medical devices, avoiding subsequent health risks. “Although a fairly recent entrant, we bring innovations and maximum value that the pharmaceutical industry seeks. All our customer engagements have evolved over time. Our customers recognize us for the bandwidth of our products and extreme innovation that can deter counterfeiters and provide convenience,” explains Amit Shah, Joint President-Flexible Packaging business. The company’s defining strategy is its expertise in engaging with a cross-section of teams within the customer organization to understand not only their visible but also latent needs to integrate the best technologies and solutions to build and preserve brands.

The R&D competency of UFlex is shouldered by its skilled personnel, who are backed by vast experience and shared passion to fuel the company’s mission of innovation

Amit Shah, Joint President, Flexible Packaging business

Understanding the customers’ vision in detail, Uflex collaborates with its business and allied teams to create a documented product development plan and starts making samples. The success of this effort, however, depends on the preferences of the brand owner, which are often iterated and refined as the project evolves. Considering the growing awareness of counterfeiting, the firm prioritizes educating the customers by providing additional insights on the possibilities of technology and prowess through scheduled interactions, which can also lead to modifications in needs. The samples undergo rigorous testing in both its labs and the customer’s labs before proceeding to semi-bulk trials or a soft launch. The entire process can take anywhere from 60 days to six months depending on its complexity, wherein the customer-facing activities and the upgradation of existing packages are quicker, while new product launches, especially with the sensitive packaging, relatively take longer.

The R&D competency of Uflex is equally shouldered by its skilled personnel, who are backed by vast experience and shared passion to fuel the company’s mission of innovation. They are encouraged to constantly augment their knowledge base, by extensive experiments and actively participating in customer meetings and knowledge exhibitions. In addition, Uflex designs its products through vertical and backward integration of its unique products and solutions, giving its workforce the flexibility to develop first-in-market products, like embossed flexible packaging, which was once deemed unfeasible. “We understand the significance of upgrading technology. Since its inception, my predecessors and I have striven to continuously invest in procuring a wide range of technologies, from generic to leading-edge equipment, adding them to our existing in-house portfolio. Our dedicated and excellent innovation and R&D teams further integrate these technologies into making unreplicable solutions for pharma cartons, like HRI coatings on outer packs or holography transparent films, Holography Lidding Foil and Alu- Alu, which empower pharmaceutical customers to stay ahead of counterfeiters,” shares Yogesh Kapur, Executive Vice President, Holography Business. The company also specializes in applying holography to different packaging components, encompassing PVC blister packs, foil backing, and entire medicine carton packaging. This vertical integration also adds an edge in maintaining customer IP protection and world-class quality standards throughout the process flow and supply chain, thereby underpinning Uflex’s position as a preferred business partner.

Beyond Packaging

Uflex firmly believes that being a market leader comes with great responsibility and has incorporated multiple environment-friendly measures, even before they were mandated by the government, regulatory bodies, or law. This can be evidenced in its endeavors to make its plants toluene-free in 2020 and recycle multi-layer plastic waste. In fact, the company was lauded for being the first in India to establish a recycling plant for flexible packaging waste, as noted by the eminent Davos Recycle Forum in 1995. Apart from its sustainable manufacturing processes, the company is also recognized for its global sustainability drive, ‘Project Plastic Fix’, which aims to convert ‘waste to wealth’ with the 4R approach: reduce, reuse, recycle, and return. Uflex has developed revolutionary technologies and methods, such as post-consumer-grade PCR films, ReLAM 250, the pyrolysis process, and Flexzyme, reinforcing its broader dedication to the welfare of the industry as well as the environment.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2026 India Pharma Outlook. All Rights Reserved.